Gunjan Verma - India

“The se developments come as the India government works to improve efficiency in the healthcare market and support domestic production growth in the medical device industry.”

Gunjan Verma
Managing Partner
Asia Actual India

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sign Up For Our Newsletter to Stay Informed

Sign Up

India Establishes Committees to Streamline Regulatory Framework and Address Denovo Products

Published on: October 14th, 2021

The MOH Has Formed a Committee to Address a De Novo Drugs, Cosmetics and Medical Devices Act

The Department of Health and Family Welfare under Ministry of Health has formed a committee to frame a De Novo Drugs, Cosmetics and Medical Devices Act. This comes after representations were made in the past that there is a need for additional guidance/requirements for New Drugs, Cosmetics and Medical Devices as the current act is completely obsolete dating as back as 1940. The centre has constituted a committee for framing/preparing new drugs, cosmetics and medical device laws.

This committee shall undertake pre-legislative consultations and examine the present Act, previously framed drugs and cosmetics bills and submit a draft document for a de-novo drugs, cosmetics and medical devices bill by November 30, 2021. The newly formed eight-member panel is headed by the Drugs Controller General of India (DCGI) VG Somani.

The other members of the panel are follows –

1 Dr. VG Somani Drugs Controller General of India (DCGI) Chairperson
2 Shri Rajiv Wadhawan, Director, Union Health Ministry Vice- Chairperson
3 Dr Eswara Reddy, Joint Drug Controller Member
4 Shri AK Pradhan, Joint Drug Controller Member
5 Shri NL Meena Member
6 Drug Controller of Haryana Member
7 Drug Controller of Gujarat Member
8 Drug Controller of Maharashtra Member

DoP Creates an Industry–led Forum for Streamlining of Regulatory Framework For Medical Devices

The Standing Forum of Medical Devices Associations has been constituted which will work on Streamlining the Regulatory framework for medical devices based on the views of the industry. Shri Himanshu Baid, Chairperson of Confederation of Indian Industry (CII) National Medical Technology Forum, will be the Convener of the standing forum. The Standing Forum will submit the report which will have recommendations to Department of Pharmaceuticals by 2nd October 2021.

Come Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market.

Contact Asia Actual today with any questions regarding medical device market access in India.

Blog Posts

Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Read more
Thai FDA Documentation Exemptions for Concise and Full Regulatory Pathways

Thai FDA Regulatory Documentation Exemptions

March 12, 2024: the Thai FDA released draft guidance updating the list of required documentation for Full and Concise Evaluation. For manufacturers registering a medical device in Thailand, certain documents are no longer required.
Read more
Hong Kong MDD adds Singapore HSA to Reference Country List

Hong Kong MDD Adds Singapore as Reference Country

Starting April 2nd, 2024, the Hong Kong Medical Device Division (MDD) accepts, on a regular basis, the marketing approvals obtained from the the Health Sciences Authority (HSA) of Singapore as a support of compliance of medical device to the "Essential Principles of Safety and Performance of Medical Devices" (Technical Reference: TR-004) under MDACS.
Read more